Barbara Lubash is a director and advisor for corporate and non-profit boards. She serves on the boards of Advanced ICU Care, CareConnectMD, Clew Medical, and the Solve ME/CFS (Chronic Fatigue Syndrome) Initiative. Barbara is a member of the Mass General Brigham Innovation advisory board, the health policy and management executive council of the Harvard T.H. Chan School of Public Health and is an advisor to STEMAdvantage.
In her prior careers as a health care executive and venture capitalist, Barbara led and advised innovative health care and service organizations. She was co-founder and managing director of Versant Ventures, and before that, a venture partner at Crosspoint Ventures. Prior corporate boards include CodeRyte (acquired by 3M), Cogent Healthcare (acquired by Sound Physicians), Concerto HealthCare, Redbrick Health (Virgin Pulse), Titan Health (acquired by USPI), and Vantage Oncology (acquired by McKesson). She was board chair of the California HealthCare Foundation, where she led the early development of its PRI impact investment strategy (Innovation Fund). She was also a senior executive at PacifiCare Health Systems (acquired by United) and Private Healthcare Systems, a national PPO, and held management roles at Hewlett Packard and the Harvard Community Health Plan (Harvard Pilgrim). She received a bachelor of science from Tufts University, and a masters in health policy and management from Harvard University. She has completed board of directors training at Stanford Directors College.